Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
837.00    17.00 (2.07%)
Bid:
836.00
Ask:
837.00
Spread: 1.00 (0.12%)
Market Cap: £790.50m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

12 Jan 2017 07:00

RNS Number : 9517T
Polar Capital Holdings PLC
12 January 2017
 

12 January 2017

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the boutique investment management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 December 2016 its AUM were £8.4bn compared to £7.3bn at the end of March 2016.

 

AUM movement in

nine months to

31 December 2016

USD

GBP

Long only

Funds

Alternative funds

Total

Long only

funds

Alternative funds

Total

AUM at

31 March 2016

$9,378m

$1,054m

$10,432m

£6,531m

£734m

£7,265m

Net subscriptions

/ (redemptions)

$(722)m

$56m

$(666)m

£(493)m

£45m

£(448)m

Market movement

and performance

$653m

$(45)m

$608m

£1,506m

£84m

£1,590m

Total AUM at

31 December 2016

$9,309m

$1,065m

$10,374m

£7,544m

£863m

£8,407m

 

Comment

 

In mid-December we released our interim results and at the time provided guidance that the US election result in November had triggered a noticeable change in flows into our funds. December has continued in the same vein that November finished and it is pleasing to report that more than £100m of net inflows were received in the month into our products, giving a total net flow for the quarter of over £300m.

 

On a less positive note the performance fees earned in the year were below the level of last year although this was the 16th consecutive year that such fees have been earned.

 

Whilst this was not our best year in terms of overall investment performance, our medium and longer term performance numbers on our UCITS products remain extremely strong, as shown in the table below. Thirteen of our eighteen Lipper rated UCITS funds are top quartile since launch, eight of which are top decile, whilst the other five funds are second quartile (as at 31 December 2016).

 

1 year

3 years

5 years

Since

inception

1st quartile

7 funds

8 funds

6 funds

13 funds

2nd quartile

5 funds

2 funds

2 funds

5 funds

3rd quartile

6 funds

3 funds

1 fund

0 funds

4th quartile

0 funds

1 fund

1 fund

0 funds

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first nine months of the Group's financial year.

 

Performance fees

net of staff allocations

Nine months to

31 Dec 15

Year to

31 Mar 16

(year-end)

Nine months to

31 Dec 16

Received

£3.0m

£3.0m

£1.1m

Accrued but not yet earned in funds with year ends on or before the financial year end

-

-

-

Total net performance fees

£3.0m

£3.0m

£1.1m

 

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Andrew Buchanan

Kit Stephenson

+44 (0)20 7523 8000

 

Peel Hunt - Joint Broker

Guy Wiehahn

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDEAXFFFFDXEFF
Date   Source Headline
18th Sep 202011:20 amRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
10th Sep 202012:26 pmRNSForm 8.3 - HASTINGS GROUP
6th Aug 20203:31 pmRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
3rd Aug 20207:00 amRNSBlock listing Interim Review
3rd Aug 20207:00 amRNSTotal Voting Rights
31st Jul 20207:30 amRNSIssue of Equity
30th Jul 20205:23 pmRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
29th Jul 20207:00 amRNSResult of AGM
22nd Jul 20204:15 pmRNSIssue of Equity
22nd Jul 202012:10 pmRNSDirector/PDMR Shareholding
10th Jul 20202:07 pmRNSDirector/PDMR Shareholding
10th Jul 20202:06 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSAuM Update
7th Jul 20208:03 amRNSHolding(s) in Company
6th Jul 202010:08 amRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20209:19 amRNSDirector/PDMR Shareholding
1st Jul 20202:10 pmRNSIssue of Equity
1st Jul 20207:00 amRNSTotal Voting Rights
29th Jun 202010:03 amRNSDirector/PDMR Shareholding
26th Jun 20201:10 pmRNSAnnual Financial Report
25th Jun 202010:26 amRNSHolding(s) in Company
25th Jun 202010:25 amRNSDirector/PDMR Shareholding
24th Jun 20203:29 pmRNSIssue of Equity
22nd Jun 20204:04 pmRNSDividend Declaration
22nd Jun 20207:00 amRNSGroup Audited Results for year ended 31 March 2020
18th Jun 202012:08 pmRNSSecond Price Monitoring Extn
18th Jun 202012:02 pmRNSPrice Monitoring Extension
5th Jun 202010:31 amRNSDirector/PDMR Shareholding
4th Jun 20207:16 amRNSNotice of Results
1st Jun 20207:00 amRNSTotal Voting Rights
19th May 20202:00 pmRNSIssue of Equity
12th May 202010:22 amRNSDirector/PDMR Shareholding
11th May 20201:15 pmRNSDirectorate Change
6th May 202011:36 amRNSHolding(s) in Company
4th May 20201:07 pmRNSIssue of Equity
4th May 202011:24 amRNSDirector/PDMR Shareholding
15th Apr 202012:00 pmRNSFund Termination
9th Apr 20204:26 pmRNSDirectorate Change
9th Apr 202012:02 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSAuM Update
7th Apr 20204:40 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSBoard Changes
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.